Researchers from Massachusetts General Hospital (MGH) Immunobiology Laboratory announce findings from a phase I clinical trial that shows the generic drug BCG (bacillus Calmette-Guerin) transiently reversed type 1 diabetes in humans.
According to Denise Faustman, MD, PhD, director of MGH, “We found that even low doses of BCG could transiently reverse type 1 diabetes in human patients.”
“LIKE” EmaxHealth news on Facebook to receive links to important articles in your Facebook feed!
Here's Why Your Diabetes Puts You at Greater Risk for a Broken Bone: Click “Next” below!
The Diabetes Site is a place where people can come together to help those whose lives have been affected by diabetes. In addition to sharing inspiring stories, shopping for the cause, and signing petitions, visitors can take just a moment each day to c lick on the red button to provide much-needed support for diabetes research. Visit The Diabetes Site and click today - it's free!
Sign up for news and offers!
Get the latest from The Diabetes Site in your inbox every morning!